Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06965127 · ClinicalTrials.gov registry record · NA

Implant for Walking After Incomplete SCI

A NA study of Gait and Spinal Cord Injury (SCI), sponsored by Louis Stokes VA Medical Center.

Recruiting
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT06965127: Recruiting NA study of Gait and Spinal Cord Injury (SCI), sponsored by Louis Stokes VA Medical Center.

NCT06965127 is a NA study of Gait and Spinal Cord Injury (SCI) that is actively recruiting participants, run by Louis Stokes VA Medical Center. The registered enrollment target is 5 participants, below the 43-participant average among 5 other Gait trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06965127, a NA study of Gait and Spinal Cord Injury (SCI), is actively recruiting participants, sponsored by Louis Stokes VA Medical Center.

RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

This is a device study that will evaluate the effect of an implanted stimulator on improving walking in people with incomplete spinal cord injury. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller development, and evaluation - this phase includes implanting the device and setting the individual up for system use, creating controllers for walking, and evaluating the effect of the device over a couple years.

Primary Outcome

The maximum walking distance is a measure of how far the participant can walk within a single bout over an unconstrained period of time. The measure is used to assess whether endurance and walking capacity improve. The difference between walking with and without the system turned on determines if the system improves walking capacity. Users serve as their own concurrent controls.

Interventions

  • DEVICE NNP-LE

Study Locations (1)

Ohio

  • Louis Stokes Cleveland Veterans Affairs Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2025-08-27
Est. Completion 2031-08
Phase NA
Louis Stokes VA Medical Center

10 total trials

What NCT06965127 shows while recruiting

NCT06965127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 43-participant average among 5 other Gait trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Gait appearing as the primary indexed condition, and to 1 intervention - of which NNP-LE is the first listed.

NCT06965127 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06965127 about?

NCT06965127 is a clinical study titled "Implant for Walking After Incomplete SCI". This is a device study that will evaluate the effect of an implanted stimulator on improving walking in people with incomplete spinal cord injury. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implanta...

What is the current status of trial NCT06965127?

This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-08-27. Estimated completion is 2031-08.

What conditions does trial NCT06965127 study?

This clinical trial studies the following conditions: Gait, Spinal Cord Injury (SCI).

What interventions are being tested in trial NCT06965127?

The interventions under investigation include: NNP-LE (DEVICE).

Who is sponsoring clinical trial NCT06965127?

This trial is sponsored by Louis Stokes VA Medical Center, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06965127 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gait

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06965127, the US trial registry maintained by the National Library of Medicine. NCT06965127 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.